2-[4-(2-tert-butyl-9,9-dimethylacridin-10-yl)phenyl]-[1,3]oxazolo[5,4-b]pyridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1,4,5-triphenylimidazol-2-yl)phenyl]acridine

C188H172N18O — CID 157102050

IUPAC2-[4-(2-tert-butyl-9,9-dimethylacridin-10-yl)phenyl]-[1,3]oxazolo[5,4-b]pyridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1,4,5-triphenylimidazol-2-yl)phenyl]acridine
SMILESCC(C)(C)c1ccc2c(c1)C(C)(C)c1ccccc1N2c1ccc(-c2nc(-c3ccccc3)c(-c3ccccc3)n2-c2ccccc2)cc1.CC(C)(C)c1ccc2c(c1)C(C)(C)c1ccccc1N2c1ccc(-c2nc3cccnc3o2)cc1.CC(C)(C)c1ccc2c(c1)C(C)(C)c1ccccc1N2c1ccc(-c2nc3ccncc3n2-c2ccccc2)cc1.CC(C)(C)c1ccc2c(c1)C(C)(C)c1ccccc1N2c1ccc(-c2nc3cnccc3n2-c2ccccc2)cc1.CC(C)(C)c1ccc2c(c1)C(C)(C)c1ccccc1N2c1ccc(-c2nc3ncccc3n2-c2ccccc2)cc1
InChIInChI=1S/C46H41N3.3C37H34N4.C31H29N3O/c1-45(2,3)35-27-30-41-39(31-35)46(4,5)38-23-15-16-24-40(38)48(41)37-28-25-34(26-29-37)44-47-42(32-17-9-6-10-18-32)43(33-19-11-7-12-20-33)49(44)36-21-13-8-14-22-36;1-36(2,3)26-19-22-32-30(24-26)37(4,5)29-14-9-10-15-31(29)40(32)28-20-17-25(18-21-28)35-39-34-33(16-11-23-38-34)41(35)27-12-7-6-8-13-27;1-36(2,3)26-17-20-33-30(23-26)37(4,5)29-13-9-10-14-32(29)40(33)28-18-15-25(16-19-28)35-39-31-24-38-22-21-34(31)41(35)27-11-7-6-8-12-27;1-36(2,3)26-17-20-33-30(23-26)37(4,5)29-13-9-10-14-32(29)40(33)28-18-15-25(16-19-28)35-39-31-21-22-38-24-34(31)41(35)27-11-7-6-8-12-27;1-30(2,3)21-14-17-27-24(19-21)31(4,5)23-9-6-7-11-26(23)34(27)22-15-12-20(13-16-22)28-33-25-10-8-18-32-29(25)35-28/h6-31H,1-5H3;3*6-24H,1-5H3;6-19H,1-5H3
InChIKeyAFWMHAWCUZRVDY-UHFFFAOYSA-N
MW2699.57 g/mol
LogP49.06
Rot. Bonds16

About 2-[4-(2-tert-butyl-9,9-dimethylacridin-10-yl)phenyl]-[1,3]oxazolo[5,4-b]pyridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1,4,5-triphenylimidazol-2-yl)phenyl]acridine

2-[4-(2-tert-butyl-9,9-dimethylacridin-10-yl)phenyl]-[1,3]oxazolo[5,4-b]pyridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1,4,5-triphenylimidazol-2-yl)phenyl]acridine (PubChem CID 157102050) has the molecular formula C188H172N18O and a molecular weight of 2699.57 g/mol. Its IUPAC name is 2-[4-(2-tert-butyl-9,9-dimethylacridin-10-yl)phenyl]-[1,3]oxazolo[5,4-b]pyridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1,4,5-triphenylimidazol-2-yl)phenyl]acridine.

Molecular Properties

Compound Name2-[4-(2-tert-butyl-9,9-dimethylacridin-10-yl)phenyl]-[1,3]oxazolo[5,4-b]pyridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1,4,5-triphenylimidazol-2-yl)phenyl]acridine
PubChem CID157102050
Molecular FormulaC188H172N18O
Molecular Weight2699.57 g/mol
Exact Mass2697.40
IUPAC Name2-[4-(2-tert-butyl-9,9-dimethylacridin-10-yl)phenyl]-[1,3]oxazolo[5,4-b]pyridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1,4,5-triphenylimidazol-2-yl)phenyl]acridine
SMILESCC(C)(C)c1ccc2c(c1)C(C)(C)c1ccccc1N2c1ccc(-c2nc(-c3ccccc3)c(-c3ccccc3)n2-c2ccccc2)cc1.CC(C)(C)c1ccc2c(c1)C(C)(C)c1ccccc1N2c1ccc(-c2nc3cccnc3o2)cc1.CC(C)(C)c1ccc2c(c1)C(C)(C)c1ccccc1N2c1ccc(-c2nc3ccncc3n2-c2ccccc2)cc1.CC(C)(C)c1ccc2c(c1)C(C)(C)c1ccccc1N2c1ccc(-c2nc3cnccc3n2-c2ccccc2)cc1.CC(C)(C)c1ccc2c(c1)C(C)(C)c1ccccc1N2c1ccc(-c2nc3ncccc3n2-c2ccccc2)cc1
InChIInChI=1S/C46H41N3.3C37H34N4.C31H29N3O/c1-45(2,3)35-27-30-41-39(31-35)46(4,5)38-23-15-16-24-40(38)48(41)37-28-25-34(26-29-37)44-47-42(32-17-9-6-10-18-32)43(33-19-11-7-12-20-33)49(44)36-21-13-8-14-22-36;1-36(2,3)26-19-22-32-30(24-26)37(4,5)29-14-9-10-15-31(29)40(32)28-20-17-25(18-21-28)35-39-34-33(16-11-23-38-34)41(35)27-12-7-6-8-13-27;1-36(2,3)26-17-20-33-30(23-26)37(4,5)29-13-9-10-14-32(29)40(33)28-18-15-25(16-19-28)35-39-31-24-38-22-21-34(31)41(35)27-11-7-6-8-12-27;1-36(2,3)26-17-20-33-30(23-26)37(4,5)29-13-9-10-14-32(29)40(33)28-18-15-25(16-19-28)35-39-31-21-22-38-24-34(31)41(35)27-11-7-6-8-12-27;1-30(2,3)21-14-17-27-24(19-21)31(4,5)23-9-6-7-11-26(23)34(27)22-15-12-20(13-16-22)28-33-25-10-8-18-32-29(25)35-28/h6-31H,1-5H3;3*6-24H,1-5H3;6-19H,1-5H3
InChIKeyAFWMHAWCUZRVDY-UHFFFAOYSA-N
XLogP49.06
TPSA165.07 Ų
H-Bond Donors
H-Bond Acceptors19
Rotatable Bonds16
Heavy Atoms207
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002699.57
LogP ≤ 549.06
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1019

Analyze 2-[4-(2-tert-butyl-9,9-dimethylacridin-10-yl)phenyl]-[1,3]oxazolo[5,4-b]pyridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1,4,5-triphenylimidazol-2-yl)phenyl]acridine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[4-(2-tert-butyl-9,9-dimethylacridin-10-yl)phenyl]-[1,3]oxazolo[5,4-b]pyridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1,4,5-triphenylimidazol-2-yl)phenyl]acridine?
The IUPAC name of 2-[4-(2-tert-butyl-9,9-dimethylacridin-10-yl)phenyl]-[1,3]oxazolo[5,4-b]pyridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1,4,5-triphenylimidazol-2-yl)phenyl]acridine (CID 157102050) is 2-[4-(2-tert-butyl-9,9-dimethylacridin-10-yl)phenyl]-[1,3]oxazolo[5,4-b]pyridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1,4,5-triphenylimidazol-2-yl)phenyl]acridine.
What is the SMILES notation for 2-[4-(2-tert-butyl-9,9-dimethylacridin-10-yl)phenyl]-[1,3]oxazolo[5,4-b]pyridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1,4,5-triphenylimidazol-2-yl)phenyl]acridine?
The canonical SMILES for 2-[4-(2-tert-butyl-9,9-dimethylacridin-10-yl)phenyl]-[1,3]oxazolo[5,4-b]pyridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1,4,5-triphenylimidazol-2-yl)phenyl]acridine is CC(C)(C)c1ccc2c(c1)C(C)(C)c1ccccc1N2c1ccc(-c2nc(-c3ccccc3)c(-c3ccccc3)n2-c2ccccc2)cc1.CC(C)(C)c1ccc2c(c1)C(C)(C)c1ccccc1N2c1ccc(-c2nc3cccnc3o2)cc1.CC(C)(C)c1ccc2c(c1)C(C)(C)c1ccccc1N2c1ccc(-c2nc3ccncc3n2-c2ccccc2)cc1.CC(C)(C)c1ccc2c(c1)C(C)(C)c1ccccc1N2c1ccc(-c2nc3cnccc3n2-c2ccccc2)cc1.CC(C)(C)c1ccc2c(c1)C(C)(C)c1ccccc1N2c1ccc(-c2nc3ncccc3n2-c2ccccc2)cc1.
What is the InChIKey of 2-[4-(2-tert-butyl-9,9-dimethylacridin-10-yl)phenyl]-[1,3]oxazolo[5,4-b]pyridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1,4,5-triphenylimidazol-2-yl)phenyl]acridine?
The InChIKey is AFWMHAWCUZRVDY-UHFFFAOYSA-N. The full InChI is InChI=1S/C46H41N3.3C37H34N4.C31H29N3O/c1-45(2,3)35-27-30-41-39(31-35)46(4,5)38-23-15-16-24-40(38)48(41)37-28-25-34(26-29-37)44-47-42(32-17-9-6-10-18-32)43(33-19-11-7-12-20-33)49(44)36-21-13-8-14-22-36;1-36(2,3)26-19-22-32-30(24-26)37(4,5)29-14-9-10-15-31(29)40(32)28-20-17-25(18-21-28)35-39-34-33(16-11-23-38-34)41(35)27-12-7-6-8-13-27;1-36(2,3)26-17-20-33-30(23-26)37(4,5)29-13-9-10-14-32(29)40(33)28-18-15-25(16-19-28)35-39-31-24-38-22-21-34(31)41(35)27-11-7-6-8-12-27;1-36(2,3)26-17-20-33-30(23-26)37(4,5)29-13-9-10-14-32(29)40(33)28-18-15-25(16-19-28)35-39-31-21-22-38-24-34(31)41(35)27-11-7-6-8-12-27;1-30(2,3)21-14-17-27-24(19-21)31(4,5)23-9-6-7-11-26(23)34(27)22-15-12-20(13-16-22)28-33-25-10-8-18-32-29(25)35-28/h6-31H,1-5H3;3*6-24H,1-5H3;6-19H,1-5H3.
What are the key properties of 2-[4-(2-tert-butyl-9,9-dimethylacridin-10-yl)phenyl]-[1,3]oxazolo[5,4-b]pyridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1,4,5-triphenylimidazol-2-yl)phenyl]acridine?
2-[4-(2-tert-butyl-9,9-dimethylacridin-10-yl)phenyl]-[1,3]oxazolo[5,4-b]pyridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1,4,5-triphenylimidazol-2-yl)phenyl]acridine has a molecular weight of 2699.57 g/mol, XLogP of 49.06, 16 rotatable bonds, 0 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-(2-tert-butyl-9,9-dimethylacridin-10-yl)phenyl]-[1,3]oxazolo[5,4-b]pyridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(3-phenylimidazo[4,5-c]pyridin-2-yl)phenyl]acridine;2-tert-butyl-9,9-dimethyl-10-[4-(1,4,5-triphenylimidazol-2-yl)phenyl]acridine is sourced from PubChem (CID 157102050), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).